Home/ Supplements/ Iron/ Ferrocite Tablets

Ferrocite Tablets

product on market Tablet or Pill Breckenridge Pharmaceutical Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Ferrocite Tablets
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
100
Servings
Mineral
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Iron
106 mg (588% DV)

Other Ingredients

Microcrystalline Cellulose Citric Acid Croscarmellose Sodium Stearic Acid Magnesium Stearate Hypromellose Titanium Dioxide Triacetin Mineral Oil FD&C Yellow #5 Lake Sodium Lauryl Sulfate FD&C Blue No.1 Lake
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Indication: For the dietary supplementation of iron deficiencies.

Dosage and Administration Usual adult dosage is one tablet daily, between meals, or as directed by a physician or health-care provider. Do not exceed recommended dosage. Do not administer to children.

Warnings & Precautions

Contains FD&C Yellow No. 5 Lake (Tartrazine) as a color additive (see Precautions).

Warning: Do not exceed recommended dosage. The dietary supplementation of any anemic condition should be under the advice and supervision of a physician. Since oral iron products interfere with absorption of certain antibiotics, these products should not be taken within two hours of each other. Gastrointestinal disturbance (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and subside with continuation of therapy.

Consult your doctor before use if you have, or have had, any health condition or if you are taking any medications (prescription or OTC).

Precautions This product contains FD&C Yellow No. 5 Lake (tartrazine) which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 Lake (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.

If pregnant, or planning to become pregnant or are currently breast-feeding, please contact your physician, or health-care provider before using or continuing use.

Do not exceed recommended dosage.

Do not administer to children. Warning: Keep this and all medications out of the reach of children.

Warning: Cancer and Reproductive Harm - www.P65Warnings.ca.gov

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Do not use if blister seals are broken

To report a serious adverse event contact: 1-800-367-3395.

Formulation Notes

Iron (from 324 mg as Ferrous Fumarate)

Additional Information

How Supplied Ferrocite Tablets are round, green, film-coated tablets debossed, “B181”. Supplied in boxes of 100 tablets (4 x 25). 51991-181-42

Storage: Store at 25 degrees C (77 degrees F); excursions permitted to 15 degrees - 30 degrees C (59 degrees - 86 degrees F). See USP Controlled Room Temperature. Protect from light and moisture.

All substitutions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product.

Breckenridge A Towa company

(4 Blister Cards with 25 Tablets each)

Metadata

Product Details

UPC / SKU3 51991 18142 2
DSLD Entry Date2020-07-23
Product TypeMineral
FormTablet or Pill
DSLD ID230128
Data Updated2026-04-11
Research

Research Evidence

566
Research Sources
56
Avg Quality
240
Meta Analysis
100
Clinical Trial
74
Systematic Review
71
Guideline
58
Rct
11
Cochrane Review
4
Regulatory Source
2
Other
2
Narrative Review
1
Observational
1
Openfda Safety
A Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency
Meta Analysis Nature medicine 2025 PubMed DOI
A Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Serum or plasma ferritin concentration as an index of iron deficiency and overload
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Non-invasive diagnostic tests for Helicobacter pylori infection
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
A Wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Fortification of condiments and seasonings with iron for preventing anaemia and improving health
Meta Analysis The Cochrane database of systematic reviews 2023 PubMed DOI
A Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement.
Guideline JAMA 2024 PubMed DOI
A Psychiatric and cognitive outcomes of iron supplementation in non-anemic children, adolescents, and menstruating adults: A meta-analysis and systematic review
Meta Analysis Neuroscience and biobehavioral reviews 2025 PubMed DOI
View all evidence for Iron →
Compare

Similar Products

View all Iron products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.